SCHEMBL4185319

SCHEMBL4185319

COc1ccc(CS(=O)(=O)/C(C#N)=C\c2ccc(OC)cc2OC)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C9 P11712 1/20 0.54
ALDH1A1 P00352 3/20 0.44
HPGD P15428 3/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
LY96 Q9Y6Y9 1/20 0.43
CYP1A1 P04798 3/20 0.43
CYP1B1 Q16678 3/20 0.43
MAPT P10636 3/20 0.43
TP53 P04637 1/20 0.43
MAPK1 P28482 1/20 0.43
PTK2B Q14289 1/20 0.43
TNFRSF1A P19438 1/20 0.42
POLB P06746 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
PKM P14618 1/20 0.42
NFE2L2 Q16236 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4185323 1.00 CYP1A2 (0.54) CYP1A2CYP3A4CYP2C9ALDH1A1HPGD
SCHEMBL4185315 1.00 CYP1A2 (0.54) CYP1A2CYP3A4CYP2C9ALDH1A1HPGD
SCHEMBL4176474 0.94 ALDH1A1 (0.51) CYP1A2CYP3A4CYP2C9ALDH1A1HPGD
SCHEMBL4176471 0.94 ALDH1A1 (0.51) CYP1A2CYP3A4CYP2C9ALDH1A1HPGD
SCHEMBL4176478 0.94 ALDH1A1 (0.51) CYP1A2CYP3A4CYP2C9ALDH1A1HPGD
SCHEMBL4175730 0.89 CYP1A2 (0.45) CYP1A2CYP3A4CYP2C9ALDH1A1HPGD
SCHEMBL4175733 0.89 CYP1A2 (0.45) CYP1A2CYP3A4CYP2C9ALDH1A1HPGD
SCHEMBL4175736 0.89 CYP1A2 (0.45) CYP1A2CYP3A4CYP2C9ALDH1A1HPGD
SCHEMBL4188795 0.88 KMT2A (0.49) CYP1A2CYP3A4CYP2C9ALDH1A1HPGD
SCHEMBL4188791 0.88 KMT2A (0.49) CYP1A2CYP3A4CYP2C9ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof ARSA, STS, SULT2A1 CYP1A2 1062/4885CYP3A4 2311/4885CYP2C9 1728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.